FMA
VXRT

FNY Managed Accounts’s Vaxart VXRT Stock Holding History

FNY Managed Accounts’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-227
Closed -$5.17K – 583
2015
Q2 		$5.17K Sell
227
-228
-50% -$5.6K 0.01% 369
2015
Q1 		$11.5K Buy
+455
New +$12.5K 0.01% 241

Other funds holding VXRT

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EGA
Eagle Global Advisors Houston, Texas $2.78B AUM 26.09% 1-Year Est. Return

FNY Managed Accounts's VXRT Position: Q3 2015 in Review

FNY Managed Accounts sold out of Vaxart (VXRT) in Q3 2015, closing a stake of 227 shares — an estimated $5.17K sold.

FNY Managed Accounts first reported a position in VXRT in Q1 2015 and held it in 2 quarters. The position peaked at $11.5K in Q1 2015. 52 funds tracked by Wall St. Rank hold VXRT as of Q3 2015.

  • FNY Managed Accounts reported no remaining Vaxart position as of Q3 2015 after selling out during the quarter.
  • FNY Managed Accounts sold 227 Vaxart shares in Q3 2015, an estimated $5.17K.
  • FNY Managed Accounts first reported a position in Vaxart in Q1 2015 and held it in 2 quarters.
  • FNY Managed Accounts's Vaxart position peaked at $11.5K in Q1 2015.
  • 52 funds tracked by Wall St. Rank held Vaxart as of Q3 2015.

Based on FNY Managed Accounts's 13F filing for Q3 2015, filed 27 Oct 2015.